Phospholamban Inhibits Ca-ATPase Conformational Changes Involving the E2 Intermediate

We have used steady-state fluorescence spectroscopy in combination with enzyme kinetic assays to test the hypothesis that phospholamban (PLB) stabilizes the Ca-ATPase in the E2 intermediate state. The cardiac muscle Ca-ATPase (SERCA2a) isoform was expressed either alone or coexpressed with PLB in Hi...

Full description

Saved in:
Bibliographic Details
Published inBiochemistry (Easton) Vol. 46; no. 7; pp. 1999 - 2009
Main Authors Waggoner, Jason R, Huffman, Jamie, Froehlich, Jeffrey P, Mahaney, James E
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 20.02.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We have used steady-state fluorescence spectroscopy in combination with enzyme kinetic assays to test the hypothesis that phospholamban (PLB) stabilizes the Ca-ATPase in the E2 intermediate state. The cardiac muscle Ca-ATPase (SERCA2a) isoform was expressed either alone or coexpressed with PLB in High-Five insect cells and was isolated as insect cell microsomes. Fluorescence studies of the Ca-ATPase covalently labeled with the probe 5-(2-((iodoacetyl)amino)ethyl)aminonaphthalene-1-sulfonic acid showed that PLB decreased the amplitude of the Ca-ATPase E2 → E1 conformational transition by 45 ± 3% and shifted the [Ca2+] dependence of the transition to higher Ca2+ levels (ΔK Ca = 230 nM), similar to the effect of PLB on Ca-ATPase activity. Similarly, PLB decreased the amplitude of Ca-ATPase phosphorylation by inorganic phosphate (Pi) by 55 ± 2% and decreased slightly the affinity for Pi (ΔK 0.5 = 70 μM). However, PLB did not affect the Ca2+-dependent inhibition of Ca-ATPase phosphorylation by Pi. Finally, PLB decreased Ca-ATPase sensitivity to vanadate, increasing the IC50 value by 300 nM. The results suggest that PLB binding to Ca-ATPase stabilizes the enzyme in a conformation distinct from E2, decreasing the number of enzymes in the E2 state capable of undergoing ligand-dependent conformational changes involving the Ca-free E2 intermediate. The inability of conformation-specific ligands to fully convert this E2-like state into E1 or E2 implies that these states are not in a simple equilibrium relationship.
Bibliography:istex:E244D68F539BD9A3BB281C8D218716A9C856F7BF
This work was supported by grants from the American Heart Association to J.R.W. (AHA 0215055B), J.P.F. (AHA 0555534U), and J.E.M. (AHA 0040094N).
ark:/67375/TPS-L0967DV0-R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-2960
1520-4995
DOI:10.1021/bi061365k